120
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood–brain barrier in rats

, , , , , , , & show all
Pages 1885-1898 | Published online: 10 Mar 2015

References

  • BertrandNLerouxJ-CThe journey of a drug-carrier in the body: an anatomo-physiological perspectiveJ Control Release2012161215216322001607
  • DindaSCPattnaikGNanobiotechnology-based drug delivery in brain targetingCurr Pharm Biotechnol201414151264127424910011
  • MorosMMitchellSGGrazuVde la FuenteJMThe fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcomeCurr Med Chem201320222759277823627938
  • BernackiJDobrowolskaANierwinskaKMaleckiAPhysiology and pharmacological role of the blood-brain barrierPharmacol Rep200860560062219066407
  • AlyautdinRKhalinINafeezaMIHaronMHKuznetsovDNanoscale drug delivery systems and the blood–brain barrierInt J Nanomedicine2014979581124550672
  • DominguezASuarez-MerinoBGoni-de-CerioFNanoparticles and blood–brain barrier: the key to central nervous system diseasesJ Nanosci Nanotechnol201414176677924730296
  • XuGMahajanSRoyIYongKTTheranostic quantum dots for crossing blood–brain barrier and providing therapy of HIV-associated encephalopathyFront Pharmacol2013414024298256
  • GabathulerRDevelopment of new peptide vectors for the transport of therapeutic across the blood–brain barrierTher Deliv20101457158622833968
  • JonesATGateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptidesInt J Pharm20083541–2343818068916
  • GaldieroSVitielloMFalangaACantisaniMIncoronatoNGaldieroMIntracellular delivery: exploiting viral membranotropic peptidesCurr Drug Metab20121319310422292812
  • VoneschCUnserMA fast thresholded landweber algorithm for wavelet-regularized multidimensional deconvolutionIEEE Trans Image Process200817453954918390362
  • GaldieroSVitielloMD’IsantoMThe identification and characterization of fusogenic domains in herpes virus glycoprotein B moleculesChembiochem20089575876718311743
  • GaldieroSFalangaAVitielloMThe presence of a single N-terminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type 1 glycoprotein HJ Biol Chem201028522171231713620348105
  • GaldieroSFalangaAVitielloMAnalysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein HJ Biol Chem200828344299933000918678872
  • GaldieroSFalangaAMorelliGGaldieroMgH625: a milestone in understanding the many roles of membranotropic peptidesBiochim Biophys Acta201518481 Pt A162525305339
  • FalangaAVitielloMTCantisaniMA peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dotsNanomedicine20117692593421664490
  • SmaldoneGFalangaACapassoDgH625 is a viral derived peptide for effective delivery of intrinsically disordered proteinsInt J Nanomedicine201382555256523901273
  • TaralloRAccardoAFalangaAClickable functionalization of liposomes with the gH625 peptide from herpes simplex virus type I for intracellular drug deliveryChemistry20111745126591266821956538
  • GuarnieriDFalangaAMuscettiOShuttle-mediated nanoparticle delivery to the blood–brain barrierSmall20139685386223135878
  • CarberryTPTaralloRFalangaADendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular deliveryChemistry20121843136781368522968943
  • FalangaATaralloRGaldieroECantisaniMGaldieroMGaldieroSReview of a viral peptide nanosystem for intracellular deliveryInt J Nanomedicine201371071599
  • RapaportDShaiYInteraction of fluorescently labeled pardaxin and its analogues with lipid bilayersJ Biol Chem19912663523769237751748653
  • BaschongWSuetterlinRLaengRHControl of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM)J Histochem Cytochem200149121565157211724904
  • ViegasMSMartinsTCSecoFdo CarmoAAn improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissuesEur J Histochem2007511596617548270
  • JaskolskiFMulleCManzoniOJAn automated method to quantify and visualize colocalized fluorescent signalsJ Neurosci Methods20051461424915935219
  • LanniAMorenoMLombardiAGogliaFCalorigenic effect of diiodothyronines in the ratJ Physiol1996494Pt 38318378865078
  • LuCTZhaoYZWongHLCaiJPengLTianXQCurrent approaches to enhance CNS delivery of drugs across the brain barriersInt J Nanomedicine201492241225724872687
  • PatelMMGoyalBRBhadadaSVBhattJSAminAFGetting into the brain: approaches to enhance brain drug deliveryCNS Drugs2009231355819062774
  • DemeuleMRéginaAAnnabiBBertrandYBojanowskiMBéliveauRBrain endothelial cells as pharmacological targets in brain tumorsMol Neurobiol200430215718315475625
  • PardridgeWMBlood–brain barrier deliveryDrug Discov Today2007121–2546117198973
  • DoolittleNDMinerMEHallWASafety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumorsCancer200088363764710649259
  • HallWDoolittleNDamanMOsmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomasJ Neurooncol200677327928416314949
  • FawellSSeeryJDaikhYTat-mediated delivery of heterologous proteins into cellsProc Natl Acad Sci U S A19949126646688290579
  • Schutze-RedelmeierMPGournierHGarcia-PonsFIntroduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivoJ Immunol199615726506558752913
  • BorlonganCVEmerichDFFacilitation of drug entry into the CNS via transient permeation of blood–brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, CereportBrain Res Bull200360329730612754091